0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Psoriatic Arthritis Therapeutics Drug Market Research Report 2024
Published Date: February 2024
|
Report Code: QYRE-Auto-7G14359
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Psoriatic Arthritis Therapeutics Drug Market Research Report 2023
BUY CHAPTERS

Global Psoriatic Arthritis Therapeutics Drug Market Research Report 2024

Code: QYRE-Auto-7G14359
Report
February 2024
Pages:93
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Psoriatic Arthritis Therapeutics Drug Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Psoriatic Arthritis Therapeutics Drug Market

Psoriatic Arthritis Therapeutics Drug Market

Psoriatic arthritis is a chronic autoimmune inflammatory disorder that causes inflammation, swelling, and stiffness at any joint of the body. Psoriatic arthritis is a progressive form of psoriasis, characterized by the itchy, scaly red patches on the skin.
The global Psoriatic Arthritis Therapeutics Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Psoriatic Arthritis Therapeutics Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Psoriatic Arthritis Therapeutics Drug.

Report Scope

The Psoriatic Arthritis Therapeutics Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Psoriatic Arthritis Therapeutics Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Psoriatic Arthritis Therapeutics Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Psoriatic Arthritis Therapeutics Drug Market Report

Report Metric Details
Report Name Psoriatic Arthritis Therapeutics Drug Market
CAGR 5%
Segment by Type
  • NF Inhibitors
  • Interleukin Inhibitors
  • PDE4 Inhibitors
  • Others
Segment by Application
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company AbbVie, Janssen Biotech, Novartis, Amgen, CELGENE CORPORATION, Pfizer, Eli Lilly, UCB, Biogen, Bristol-Myers Squibb
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Psoriatic Arthritis Therapeutics Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Psoriatic Arthritis Therapeutics Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Psoriatic Arthritis Therapeutics Drug Market report?

Ans: The main players in the Psoriatic Arthritis Therapeutics Drug Market are AbbVie, Janssen Biotech, Novartis, Amgen, CELGENE CORPORATION, Pfizer, Eli Lilly, UCB, Biogen, Bristol-Myers Squibb

What are the Application segmentation covered in the Psoriatic Arthritis Therapeutics Drug Market report?

Ans: The Applications covered in the Psoriatic Arthritis Therapeutics Drug Market report are Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

What are the Type segmentation covered in the Psoriatic Arthritis Therapeutics Drug Market report?

Ans: The Types covered in the Psoriatic Arthritis Therapeutics Drug Market report are NF Inhibitors, Interleukin Inhibitors, PDE4 Inhibitors, Others

1 Psoriatic Arthritis Therapeutics Drug Market Overview
1.1 Product Overview and Scope of Psoriatic Arthritis Therapeutics Drug
1.2 Psoriatic Arthritis Therapeutics Drug Segment by Type
1.2.1 Global Psoriatic Arthritis Therapeutics Drug Market Value Comparison by Type (2024-2030)
1.2.2 NF Inhibitors
1.2.3 Interleukin Inhibitors
1.2.4 PDE4 Inhibitors
1.2.5 Others
1.3 Psoriatic Arthritis Therapeutics Drug Segment by Application
1.3.1 Global Psoriatic Arthritis Therapeutics Drug Market Value by Application: (2024-2030)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Global Psoriatic Arthritis Therapeutics Drug Market Size Estimates and Forecasts
1.4.1 Global Psoriatic Arthritis Therapeutics Drug Revenue 2019-2030
1.4.2 Global Psoriatic Arthritis Therapeutics Drug Sales 2019-2030
1.4.3 Global Psoriatic Arthritis Therapeutics Drug Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Psoriatic Arthritis Therapeutics Drug Market Competition by Manufacturers
2.1 Global Psoriatic Arthritis Therapeutics Drug Sales Market Share by Manufacturers (2019-2024)
2.2 Global Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Psoriatic Arthritis Therapeutics Drug Average Price by Manufacturers (2019-2024)
2.4 Global Psoriatic Arthritis Therapeutics Drug Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Psoriatic Arthritis Therapeutics Drug, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Psoriatic Arthritis Therapeutics Drug, Product Type & Application
2.7 Psoriatic Arthritis Therapeutics Drug Market Competitive Situation and Trends
2.7.1 Psoriatic Arthritis Therapeutics Drug Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Psoriatic Arthritis Therapeutics Drug Players Market Share by Revenue
2.7.3 Global Psoriatic Arthritis Therapeutics Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Psoriatic Arthritis Therapeutics Drug Retrospective Market Scenario by Region
3.1 Global Psoriatic Arthritis Therapeutics Drug Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Psoriatic Arthritis Therapeutics Drug Global Psoriatic Arthritis Therapeutics Drug Sales by Region: 2019-2030
3.2.1 Global Psoriatic Arthritis Therapeutics Drug Sales by Region: 2019-2024
3.2.2 Global Psoriatic Arthritis Therapeutics Drug Sales by Region: 2025-2030
3.3 Global Psoriatic Arthritis Therapeutics Drug Global Psoriatic Arthritis Therapeutics Drug Revenue by Region: 2019-2030
3.3.1 Global Psoriatic Arthritis Therapeutics Drug Revenue by Region: 2019-2024
3.3.2 Global Psoriatic Arthritis Therapeutics Drug Revenue by Region: 2025-2030
3.4 North America Psoriatic Arthritis Therapeutics Drug Market Facts & Figures by Country
3.4.1 North America Psoriatic Arthritis Therapeutics Drug Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Psoriatic Arthritis Therapeutics Drug Sales by Country (2019-2030)
3.4.3 North America Psoriatic Arthritis Therapeutics Drug Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Psoriatic Arthritis Therapeutics Drug Market Facts & Figures by Country
3.5.1 Europe Psoriatic Arthritis Therapeutics Drug Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Psoriatic Arthritis Therapeutics Drug Sales by Country (2019-2030)
3.5.3 Europe Psoriatic Arthritis Therapeutics Drug Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Psoriatic Arthritis Therapeutics Drug Market Facts & Figures by Country
3.6.1 Asia Pacific Psoriatic Arthritis Therapeutics Drug Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Psoriatic Arthritis Therapeutics Drug Sales by Country (2019-2030)
3.6.3 Asia Pacific Psoriatic Arthritis Therapeutics Drug Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Psoriatic Arthritis Therapeutics Drug Market Facts & Figures by Country
3.7.1 Latin America Psoriatic Arthritis Therapeutics Drug Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Psoriatic Arthritis Therapeutics Drug Sales by Country (2019-2030)
3.7.3 Latin America Psoriatic Arthritis Therapeutics Drug Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Psoriatic Arthritis Therapeutics Drug Market Facts & Figures by Country
3.8.1 Middle East and Africa Psoriatic Arthritis Therapeutics Drug Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Psoriatic Arthritis Therapeutics Drug Sales by Country (2019-2030)
3.8.3 Middle East and Africa Psoriatic Arthritis Therapeutics Drug Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Psoriatic Arthritis Therapeutics Drug Sales by Type (2019-2030)
4.1.1 Global Psoriatic Arthritis Therapeutics Drug Sales by Type (2019-2024)
4.1.2 Global Psoriatic Arthritis Therapeutics Drug Sales by Type (2025-2030)
4.1.3 Global Psoriatic Arthritis Therapeutics Drug Sales Market Share by Type (2019-2030)
4.2 Global Psoriatic Arthritis Therapeutics Drug Revenue by Type (2019-2030)
4.2.1 Global Psoriatic Arthritis Therapeutics Drug Revenue by Type (2019-2024)
4.2.2 Global Psoriatic Arthritis Therapeutics Drug Revenue by Type (2025-2030)
4.2.3 Global Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Type (2019-2030)
4.3 Global Psoriatic Arthritis Therapeutics Drug Price by Type (2019-2030)
5 Segment by Application
5.1 Global Psoriatic Arthritis Therapeutics Drug Sales by Application (2019-2030)
5.1.1 Global Psoriatic Arthritis Therapeutics Drug Sales by Application (2019-2024)
5.1.2 Global Psoriatic Arthritis Therapeutics Drug Sales by Application (2025-2030)
5.1.3 Global Psoriatic Arthritis Therapeutics Drug Sales Market Share by Application (2019-2030)
5.2 Global Psoriatic Arthritis Therapeutics Drug Revenue by Application (2019-2030)
5.2.1 Global Psoriatic Arthritis Therapeutics Drug Revenue by Application (2019-2024)
5.2.2 Global Psoriatic Arthritis Therapeutics Drug Revenue by Application (2025-2030)
5.2.3 Global Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Application (2019-2030)
5.3 Global Psoriatic Arthritis Therapeutics Drug Price by Application (2019-2030)
6 Key Companies Profiled
6.1 AbbVie
6.1.1 AbbVie Corporation Information
6.1.2 AbbVie Description and Business Overview
6.1.3 AbbVie Psoriatic Arthritis Therapeutics Drug Sales, Revenue and Gross Margin (2019-2024)
6.1.4 AbbVie Psoriatic Arthritis Therapeutics Drug Product Portfolio
6.1.5 AbbVie Recent Developments/Updates
6.2 Janssen Biotech
6.2.1 Janssen Biotech Corporation Information
6.2.2 Janssen Biotech Description and Business Overview
6.2.3 Janssen Biotech Psoriatic Arthritis Therapeutics Drug Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Janssen Biotech Psoriatic Arthritis Therapeutics Drug Product Portfolio
6.2.5 Janssen Biotech Recent Developments/Updates
6.3 Novartis
6.3.1 Novartis Corporation Information
6.3.2 Novartis Description and Business Overview
6.3.3 Novartis Psoriatic Arthritis Therapeutics Drug Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Novartis Psoriatic Arthritis Therapeutics Drug Product Portfolio
6.3.5 Novartis Recent Developments/Updates
6.4 Amgen
6.4.1 Amgen Corporation Information
6.4.2 Amgen Description and Business Overview
6.4.3 Amgen Psoriatic Arthritis Therapeutics Drug Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Amgen Psoriatic Arthritis Therapeutics Drug Product Portfolio
6.4.5 Amgen Recent Developments/Updates
6.5 CELGENE CORPORATION
6.5.1 CELGENE CORPORATION Corporation Information
6.5.2 CELGENE CORPORATION Description and Business Overview
6.5.3 CELGENE CORPORATION Psoriatic Arthritis Therapeutics Drug Sales, Revenue and Gross Margin (2019-2024)
6.5.4 CELGENE CORPORATION Psoriatic Arthritis Therapeutics Drug Product Portfolio
6.5.5 CELGENE CORPORATION Recent Developments/Updates
6.6 Pfizer
6.6.1 Pfizer Corporation Information
6.6.2 Pfizer Description and Business Overview
6.6.3 Pfizer Psoriatic Arthritis Therapeutics Drug Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Pfizer Psoriatic Arthritis Therapeutics Drug Product Portfolio
6.6.5 Pfizer Recent Developments/Updates
6.7 Eli Lilly
6.6.1 Eli Lilly Corporation Information
6.6.2 Eli Lilly Description and Business Overview
6.6.3 Eli Lilly Psoriatic Arthritis Therapeutics Drug Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Eli Lilly Psoriatic Arthritis Therapeutics Drug Product Portfolio
6.7.5 Eli Lilly Recent Developments/Updates
6.8 UCB
6.8.1 UCB Corporation Information
6.8.2 UCB Description and Business Overview
6.8.3 UCB Psoriatic Arthritis Therapeutics Drug Sales, Revenue and Gross Margin (2019-2024)
6.8.4 UCB Psoriatic Arthritis Therapeutics Drug Product Portfolio
6.8.5 UCB Recent Developments/Updates
6.9 Biogen
6.9.1 Biogen Corporation Information
6.9.2 Biogen Description and Business Overview
6.9.3 Biogen Psoriatic Arthritis Therapeutics Drug Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Biogen Psoriatic Arthritis Therapeutics Drug Product Portfolio
6.9.5 Biogen Recent Developments/Updates
6.10 Bristol-Myers Squibb
6.10.1 Bristol-Myers Squibb Corporation Information
6.10.2 Bristol-Myers Squibb Description and Business Overview
6.10.3 Bristol-Myers Squibb Psoriatic Arthritis Therapeutics Drug Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Bristol-Myers Squibb Psoriatic Arthritis Therapeutics Drug Product Portfolio
6.10.5 Bristol-Myers Squibb Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Psoriatic Arthritis Therapeutics Drug Industry Chain Analysis
7.2 Psoriatic Arthritis Therapeutics Drug Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Psoriatic Arthritis Therapeutics Drug Production Mode & Process
7.4 Psoriatic Arthritis Therapeutics Drug Sales and Marketing
7.4.1 Psoriatic Arthritis Therapeutics Drug Sales Channels
7.4.2 Psoriatic Arthritis Therapeutics Drug Distributors
7.5 Psoriatic Arthritis Therapeutics Drug Customers
8 Psoriatic Arthritis Therapeutics Drug Market Dynamics
8.1 Psoriatic Arthritis Therapeutics Drug Industry Trends
8.2 Psoriatic Arthritis Therapeutics Drug Market Drivers
8.3 Psoriatic Arthritis Therapeutics Drug Market Challenges
8.4 Psoriatic Arthritis Therapeutics Drug Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
    Table 1. Global Psoriatic Arthritis Therapeutics Drug Market Value Comparison by Type (2024-2030) & (US$ Million)
    Table 2. Global Psoriatic Arthritis Therapeutics Drug Market Value Comparison by Application (2024-2030) & (US$ Million)
    Table 3. Global Psoriatic Arthritis Therapeutics Drug Market Competitive Situation by Manufacturers in 2023
    Table 4. Global Psoriatic Arthritis Therapeutics Drug Sales (K Units) of Key Manufacturers (2019-2024)
    Table 5. Global Psoriatic Arthritis Therapeutics Drug Sales Market Share by Manufacturers (2019-2024)
    Table 6. Global Psoriatic Arthritis Therapeutics Drug Revenue (US$ Million) by Manufacturers (2019-2024)
    Table 7. Global Psoriatic Arthritis Therapeutics Drug Revenue Share by Manufacturers (2019-2024)
    Table 8. Global Market Psoriatic Arthritis Therapeutics Drug Average Price (USD/Unit) of Key Manufacturers (2019-2024)
    Table 9. Global Key Players of Psoriatic Arthritis Therapeutics Drug, Industry Ranking, 2022 VS 2023 VS 2024
    Table 10. Global Key Manufacturers of Psoriatic Arthritis Therapeutics Drug, Manufacturing Sites & Headquarters
    Table 11. Global Key Manufacturers of Psoriatic Arthritis Therapeutics Drug, Product Type & Application
    Table 12. Global Key Manufacturers of Psoriatic Arthritis Therapeutics Drug, Date of Enter into This Industry
    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Psoriatic Arthritis Therapeutics Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Psoriatic Arthritis Therapeutics Drug as of 2023)
    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 16. Global Psoriatic Arthritis Therapeutics Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 17. Global Psoriatic Arthritis Therapeutics Drug Sales by Region (2019-2024) & (K Units)
    Table 18. Global Psoriatic Arthritis Therapeutics Drug Sales Market Share by Region (2019-2024)
    Table 19. Global Psoriatic Arthritis Therapeutics Drug Sales by Region (2025-2030) & (K Units)
    Table 20. Global Psoriatic Arthritis Therapeutics Drug Sales Market Share by Region (2025-2030)
    Table 21. Global Psoriatic Arthritis Therapeutics Drug Revenue by Region (2019-2024) & (US$ Million)
    Table 22. Global Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Region (2019-2024)
    Table 23. Global Psoriatic Arthritis Therapeutics Drug Revenue by Region (2025-2030) & (US$ Million)
    Table 24. Global Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Region (2025-2030)
    Table 25. North America Psoriatic Arthritis Therapeutics Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 26. North America Psoriatic Arthritis Therapeutics Drug Sales by Country (2019-2024) & (K Units)
    Table 27. North America Psoriatic Arthritis Therapeutics Drug Sales by Country (2025-2030) & (K Units)
    Table 28. North America Psoriatic Arthritis Therapeutics Drug Revenue by Country (2019-2024) & (US$ Million)
    Table 29. North America Psoriatic Arthritis Therapeutics Drug Revenue by Country (2025-2030) & (US$ Million)
    Table 30. Europe Psoriatic Arthritis Therapeutics Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 31. Europe Psoriatic Arthritis Therapeutics Drug Sales by Country (2019-2024) & (K Units)
    Table 32. Europe Psoriatic Arthritis Therapeutics Drug Sales by Country (2025-2030) & (K Units)
    Table 33. Europe Psoriatic Arthritis Therapeutics Drug Revenue by Country (2019-2024) & (US$ Million)
    Table 34. Europe Psoriatic Arthritis Therapeutics Drug Revenue by Country (2025-2030) & (US$ Million)
    Table 35. Asia Pacific Psoriatic Arthritis Therapeutics Drug Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 36. Asia Pacific Psoriatic Arthritis Therapeutics Drug Sales by Region (2019-2024) & (K Units)
    Table 37. Asia Pacific Psoriatic Arthritis Therapeutics Drug Sales by Region (2025-2030) & (K Units)
    Table 38. Asia Pacific Psoriatic Arthritis Therapeutics Drug Revenue by Region (2019-2024) & (US$ Million)
    Table 39. Asia Pacific Psoriatic Arthritis Therapeutics Drug Revenue by Region (2025-2030) & (US$ Million)
    Table 40. Latin America Psoriatic Arthritis Therapeutics Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Latin America Psoriatic Arthritis Therapeutics Drug Sales by Country (2019-2024) & (K Units)
    Table 42. Latin America Psoriatic Arthritis Therapeutics Drug Sales by Country (2025-2030) & (K Units)
    Table 43. Latin America Psoriatic Arthritis Therapeutics Drug Revenue by Country (2019-2024) & (US$ Million)
    Table 44. Latin America Psoriatic Arthritis Therapeutics Drug Revenue by Country (2025-2030) & (US$ Million)
    Table 45. Middle East & Africa Psoriatic Arthritis Therapeutics Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 46. Middle East & Africa Psoriatic Arthritis Therapeutics Drug Sales by Country (2019-2024) & (K Units)
    Table 47. Middle East & Africa Psoriatic Arthritis Therapeutics Drug Sales by Country (2025-2030) & (K Units)
    Table 48. Middle East & Africa Psoriatic Arthritis Therapeutics Drug Revenue by Country (2019-2024) & (US$ Million)
    Table 49. Middle East & Africa Psoriatic Arthritis Therapeutics Drug Revenue by Country (2025-2030) & (US$ Million)
    Table 50. Global Psoriatic Arthritis Therapeutics Drug Sales (K Units) by Type (2019-2024)
    Table 51. Global Psoriatic Arthritis Therapeutics Drug Sales (K Units) by Type (2025-2030)
    Table 52. Global Psoriatic Arthritis Therapeutics Drug Sales Market Share by Type (2019-2024)
    Table 53. Global Psoriatic Arthritis Therapeutics Drug Sales Market Share by Type (2025-2030)
    Table 54. Global Psoriatic Arthritis Therapeutics Drug Revenue (US$ Million) by Type (2019-2024)
    Table 55. Global Psoriatic Arthritis Therapeutics Drug Revenue (US$ Million) by Type (2025-2030)
    Table 56. Global Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Type (2019-2024)
    Table 57. Global Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Type (2025-2030)
    Table 58. Global Psoriatic Arthritis Therapeutics Drug Price (USD/Unit) by Type (2019-2024)
    Table 59. Global Psoriatic Arthritis Therapeutics Drug Price (USD/Unit) by Type (2025-2030)
    Table 60. Global Psoriatic Arthritis Therapeutics Drug Sales (K Units) by Application (2019-2024)
    Table 61. Global Psoriatic Arthritis Therapeutics Drug Sales (K Units) by Application (2025-2030)
    Table 62. Global Psoriatic Arthritis Therapeutics Drug Sales Market Share by Application (2019-2024)
    Table 63. Global Psoriatic Arthritis Therapeutics Drug Sales Market Share by Application (2025-2030)
    Table 64. Global Psoriatic Arthritis Therapeutics Drug Revenue (US$ Million) by Application (2019-2024)
    Table 65. Global Psoriatic Arthritis Therapeutics Drug Revenue (US$ Million) by Application (2025-2030)
    Table 66. Global Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Application (2019-2024)
    Table 67. Global Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Application (2025-2030)
    Table 68. Global Psoriatic Arthritis Therapeutics Drug Price (USD/Unit) by Application (2019-2024)
    Table 69. Global Psoriatic Arthritis Therapeutics Drug Price (USD/Unit) by Application (2025-2030)
    Table 70. AbbVie Corporation Information
    Table 71. AbbVie Description and Business Overview
    Table 72. AbbVie Psoriatic Arthritis Therapeutics Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 73. AbbVie Psoriatic Arthritis Therapeutics Drug Product
    Table 74. AbbVie Recent Developments/Updates
    Table 75. Janssen Biotech Corporation Information
    Table 76. Janssen Biotech Description and Business Overview
    Table 77. Janssen Biotech Psoriatic Arthritis Therapeutics Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 78. Janssen Biotech Psoriatic Arthritis Therapeutics Drug Product
    Table 79. Janssen Biotech Recent Developments/Updates
    Table 80. Novartis Corporation Information
    Table 81. Novartis Description and Business Overview
    Table 82. Novartis Psoriatic Arthritis Therapeutics Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 83. Novartis Psoriatic Arthritis Therapeutics Drug Product
    Table 84. Novartis Recent Developments/Updates
    Table 85. Amgen Corporation Information
    Table 86. Amgen Description and Business Overview
    Table 87. Amgen Psoriatic Arthritis Therapeutics Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 88. Amgen Psoriatic Arthritis Therapeutics Drug Product
    Table 89. Amgen Recent Developments/Updates
    Table 90. CELGENE CORPORATION Corporation Information
    Table 91. CELGENE CORPORATION Description and Business Overview
    Table 92. CELGENE CORPORATION Psoriatic Arthritis Therapeutics Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 93. CELGENE CORPORATION Psoriatic Arthritis Therapeutics Drug Product
    Table 94. CELGENE CORPORATION Recent Developments/Updates
    Table 95. Pfizer Corporation Information
    Table 96. Pfizer Description and Business Overview
    Table 97. Pfizer Psoriatic Arthritis Therapeutics Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 98. Pfizer Psoriatic Arthritis Therapeutics Drug Product
    Table 99. Pfizer Recent Developments/Updates
    Table 100. Eli Lilly Corporation Information
    Table 101. Eli Lilly Description and Business Overview
    Table 102. Eli Lilly Psoriatic Arthritis Therapeutics Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 103. Eli Lilly Psoriatic Arthritis Therapeutics Drug Product
    Table 104. Eli Lilly Recent Developments/Updates
    Table 105. UCB Corporation Information
    Table 106. UCB Description and Business Overview
    Table 107. UCB Psoriatic Arthritis Therapeutics Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 108. UCB Psoriatic Arthritis Therapeutics Drug Product
    Table 109. UCB Recent Developments/Updates
    Table 110. Biogen Corporation Information
    Table 111. Biogen Description and Business Overview
    Table 112. Biogen Psoriatic Arthritis Therapeutics Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 113. Biogen Psoriatic Arthritis Therapeutics Drug Product
    Table 114. Biogen Recent Developments/Updates
    Table 115. Bristol-Myers Squibb Corporation Information
    Table 116. Bristol-Myers Squibb Description and Business Overview
    Table 117. Bristol-Myers Squibb Psoriatic Arthritis Therapeutics Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 118. Bristol-Myers Squibb Psoriatic Arthritis Therapeutics Drug Product
    Table 119. Bristol-Myers Squibb Recent Developments/Updates
    Table 120. Key Raw Materials Lists
    Table 121. Raw Materials Key Suppliers Lists
    Table 122. Psoriatic Arthritis Therapeutics Drug Distributors List
    Table 123. Psoriatic Arthritis Therapeutics Drug Customers List
    Table 124. Psoriatic Arthritis Therapeutics Drug Market Trends
    Table 125. Psoriatic Arthritis Therapeutics Drug Market Drivers
    Table 126. Psoriatic Arthritis Therapeutics Drug Market Challenges
    Table 127. Psoriatic Arthritis Therapeutics Drug Market Restraints
    Table 128. Research Programs/Design for This Report
    Table 129. Key Data Information from Secondary Sources
    Table 130. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Psoriatic Arthritis Therapeutics Drug
    Figure 2. Global Psoriatic Arthritis Therapeutics Drug Market Value Comparison by Type (2024-2030) & (US$ Million)
    Figure 3. Global Psoriatic Arthritis Therapeutics Drug Market Share by Type in 2023 & 2030
    Figure 4. NF Inhibitors Product Picture
    Figure 5. Interleukin Inhibitors Product Picture
    Figure 6. PDE4 Inhibitors Product Picture
    Figure 7. Others Product Picture
    Figure 8. Global Psoriatic Arthritis Therapeutics Drug Market Value Comparison by Application (2024-2030) & (US$ Million)
    Figure 9. Global Psoriatic Arthritis Therapeutics Drug Market Share by Application in 2023 & 2030
    Figure 10. Hospital Pharmacies
    Figure 11. Retail Pharmacies
    Figure 12. Online Pharmacies
    Figure 13. Global Psoriatic Arthritis Therapeutics Drug Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 14. Global Psoriatic Arthritis Therapeutics Drug Market Size (2019-2030) & (US$ Million)
    Figure 15. Global Psoriatic Arthritis Therapeutics Drug Sales (2019-2030) & (K Units)
    Figure 16. Global Psoriatic Arthritis Therapeutics Drug Average Price (USD/Unit) & (2019-2030)
    Figure 17. Psoriatic Arthritis Therapeutics Drug Report Years Considered
    Figure 18. Psoriatic Arthritis Therapeutics Drug Sales Share by Manufacturers in 2023
    Figure 19. Global Psoriatic Arthritis Therapeutics Drug Revenue Share by Manufacturers in 2023
    Figure 20. The Global 5 and 10 Largest Psoriatic Arthritis Therapeutics Drug Players: Market Share by Revenue in 2023
    Figure 21. Psoriatic Arthritis Therapeutics Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
    Figure 22. Global Psoriatic Arthritis Therapeutics Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Figure 23. North America Psoriatic Arthritis Therapeutics Drug Sales Market Share by Country (2019-2030)
    Figure 24. North America Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Country (2019-2030)
    Figure 25. U.S. Psoriatic Arthritis Therapeutics Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 26. Canada Psoriatic Arthritis Therapeutics Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 27. Europe Psoriatic Arthritis Therapeutics Drug Sales Market Share by Country (2019-2030)
    Figure 28. Europe Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Country (2019-2030)
    Figure 29. Germany Psoriatic Arthritis Therapeutics Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 30. France Psoriatic Arthritis Therapeutics Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 31. U.K. Psoriatic Arthritis Therapeutics Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 32. Italy Psoriatic Arthritis Therapeutics Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 33. Russia Psoriatic Arthritis Therapeutics Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 34. Asia Pacific Psoriatic Arthritis Therapeutics Drug Sales Market Share by Region (2019-2030)
    Figure 35. Asia Pacific Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Region (2019-2030)
    Figure 36. China Psoriatic Arthritis Therapeutics Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 37. Japan Psoriatic Arthritis Therapeutics Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 38. South Korea Psoriatic Arthritis Therapeutics Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 39. India Psoriatic Arthritis Therapeutics Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 40. Australia Psoriatic Arthritis Therapeutics Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 41. Taiwan Psoriatic Arthritis Therapeutics Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 42. Indonesia Psoriatic Arthritis Therapeutics Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 43. Thailand Psoriatic Arthritis Therapeutics Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 44. Malaysia Psoriatic Arthritis Therapeutics Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 45. Philippines Psoriatic Arthritis Therapeutics Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 46. Latin America Psoriatic Arthritis Therapeutics Drug Sales Market Share by Country (2019-2030)
    Figure 47. Latin America Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Country (2019-2030)
    Figure 48. Mexico Psoriatic Arthritis Therapeutics Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 49. Brazil Psoriatic Arthritis Therapeutics Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 50. Argentina Psoriatic Arthritis Therapeutics Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 51. Middle East & Africa Psoriatic Arthritis Therapeutics Drug Sales Market Share by Country (2019-2030)
    Figure 52. Middle East & Africa Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Country (2019-2030)
    Figure 53. Turkey Psoriatic Arthritis Therapeutics Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 54. Saudi Arabia Psoriatic Arthritis Therapeutics Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 55. U.A.E Psoriatic Arthritis Therapeutics Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 56. Global Sales Market Share of Psoriatic Arthritis Therapeutics Drug by Type (2019-2030)
    Figure 57. Global Revenue Market Share of Psoriatic Arthritis Therapeutics Drug by Type (2019-2030)
    Figure 58. Global Psoriatic Arthritis Therapeutics Drug Price (USD/Unit) by Type (2019-2030)
    Figure 59. Global Sales Market Share of Psoriatic Arthritis Therapeutics Drug by Application (2019-2030)
    Figure 60. Global Revenue Market Share of Psoriatic Arthritis Therapeutics Drug by Application (2019-2030)
    Figure 61. Global Psoriatic Arthritis Therapeutics Drug Price (USD/Unit) by Application (2019-2030)
    Figure 62. Psoriatic Arthritis Therapeutics Drug Value Chain
    Figure 63. Psoriatic Arthritis Therapeutics Drug Production Process
    Figure 64. Channels of Distribution (Direct Vs Distribution)
    Figure 65. Distributors Profiles
    Figure 66. Bottom-up and Top-down Approaches for This Report
    Figure 67. Data Triangulation
    Figure 68. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Leap India

SIMILAR REPORTS